The market has been neutral on 22nd Century Group Inc (XXII) stock recently. XXII gets a Neutral score from InvestorsObserver's Stock Sentiment Indicator.
22nd Century Group Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on XXII!
What is Stock Sentiment?
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With XXII Stock Today?
22nd Century Group Inc (XXII) stock is trading at $0.78 as of 2:15 PM on Wednesday, Jul 1, a gain of $0.02, or 2.16% from the previous closing price of $0.76. The stock has traded between $0.77 and $0.80 so far today. Volume today is below average. So far 412,961 shares have traded compared to average volume of 1,575,681 shares.
To see InvestorsObserver's Sentiment Score for 22nd Century Group Inc click here.
More About 22nd Century Group Inc
22nd Century Group Inc is a US-based plant biotechnology company. It focuses on developing technology which allows the increase or decrease in the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. The company is engaged in the research and development of potentially less harmful or modified risk tobacco products and novel tobacco plant varieties. Other business activities of the company include manufacture, marketing, sales and distribution of RED SUN and MAGIC proprietary cigarettes, contract manufacturing of third-party branded tobacco products, research and development of plant varieties of hemp/cannabis, the sale of branded proprietary tobaccos and among others.
